Lerner Research Institute News
Read about the latest advances from Lerner Research Institute scientists, including new findings, grant awards, innovations and collaborations.
Michael Kattan, PhD, MBA, Chair of Lerner Research Institute's Department of Quantitative Health Sciences and a joint appointee in the Cleveland Clinic Glickman Urological and Kidney Institute, has been elected a Fellow of the American Statistical Association (ASA). The formal induction ceremony will be in Vancouver this coming July. Dr. Kattan was nominated by an ASA-member peer for his excellent reputation and outstanding contributions to statistical science.
Dr. Kattan has created numerous nomograms—mathematical models sometimes called "risk calculators"—that clinicians use to help assess a patient's individual risk for cancers and other disorders and to inform targeted therapeutic strategy. The models, often called "Kattan nomograms", have already become part of the staging systems and decision-making guidelines for doctors at such prestigious institutions as Memorial Sloan-Kettering Cancer Center (where more than 100 nomograms are featured), as advocated by the American Joint Committee on Cancer. His online calculators are a valuable aspect of modern medicine's push toward more precise personalized care using "big data", primarily culled from electronic medical records. Dr. Kattan has long been a specialist in machine learning, analysis of health care data and computer modeling for medical decision making.
Dr. Kattan's collaborative work in both basic and clinical research has appeared in the New England Journal of Medicine and JAMA, as well as in statistical specialty journals. His seminal contributions to biomedicine are widely and productively applied to an impressive range of clinically relevant disorders. Dr. Kattan's publications have ranged in topic from the original prostate cancers to many genitourinary, renal and breast cancers, stroke, knee ligament reconstruction for sports injuries, and even a study of psychosis.
Dr. Kattan holds two U.S. patents on nomograms. He and his contributions to the field have been recognized with national honors, including the John M. Eisenberg Award for Practical Applications of Medical Decision Making Research (Society for Medical Decision Making). He has been a recipient of Cleveland Clinic's own Sones Innovation Award for his theoretical development and pragmatic application of risk calculators that can now be applied to heart disease, diabetes and other conditions. Dr. Kattan holds the Dr. Keyhan and Dr. Jafar Mobasseri Endowed Chair for Innovations in Cancer Research.